Skip to main content
. 2021 Aug 11;10(3):CNS76. doi: 10.2217/cns-2021-0007

Figure 2. . Survival outcomes in patients with glioblastoma multiforme and their relationship with methyltransferase promoter testing status and with methyltransferase promoter methylation status.

Figure 2. 

Figure 2. 

Figure 2. 

Figure 2. 

(A) Kaplan–Meier curves for overall survival by testing status. (B) Overall survival by methylation status. (C) Progression-free survival by testing status. (D) Progression-free survival by methylation status.

1L: First line; MGMT: O6-methylguanine-DNA methyltransferase; NA: Not available; SE: Standard error.